The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Renhe Pharmacy Co., Ltd. Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.52% CNY6.76
America/New_York / 5 mai 2024 @ 22:39
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 9 463.59 mill |
| EPS: | 0.470 |
| P/E: | 14.38 |
| Earnings Date: | Apr 26, 2024 |
| SharesOutstanding: | 1 399.94 mill |
| Avg Daily Volume: | 22.01 mill |
| RATING 2024-04-30 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.40x |
| Company: PE 14.38 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.32x |
| Company: PE 14.38 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY17.02 (151.74%) CNY10.26 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 6.38 - 6.68 ( +/- 2.31%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY6.76 (3.52% ) |
| Volume | 23.96 mill |
| Avg. Vol. | 22.01 mill |
| % of Avg. Vol | 108.88 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 000650.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
000650.SZ
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.